Ttr-mediated Amyloidosis
📧 Sign up to get email alerts when something new happens for Ttr-mediated Amyloidosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis [Phase 2]
Phase 2 clinical trial assessing safety and tolerability of patisiran (ALN-TTR02) in transthyretin amyloidosis has completed with results po…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis [Phase 2]
Phase 2 extension study evaluating Revusiran (ALN-TTRSC) in transthyretin cardiac amyloidosis has completed with posted results.